70 204

Results of a Phase II Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Patients Who Failed First-Line Therapy Containing Dacarbazine

Authors
 Choong-kun Lee  ;  Minkyu Jung  ;  Sang Joon Shin  ;  Sun Young Rha  ;  Su Jin Heo  ;  Hyun Cheol Chung  ;  Joong Bae Ahn  ;  Mi Ryung Roh  ;  Hyo Song Kim  ;  Hye Ryun Kim  ;  Hye Jin Choi 
Citation
 Cancer Research and Treatment, Vol.47(4) : 781-789, 2015 
Journal Title
 Cancer Research and Treatment 
ISSN
 1598-2998 
Issue Date
2015
Abstract
PURPOSE: There is no standard second-line regimen for malignant melanoma patients with disease progression after first-line chemotherapy, and platinum-alkylating agents combined with paclitaxel have shown modest efficacy. MATERIALS AND METHODS: We conducted a phase II, open-label, single-arm study to test the efficacy of docetaxel combined with carboplatin for malignant melanoma patients who failed previous treatment with dacarbazine. Intravenous docetaxel (35 mg/m(2) on days 1 and 8 of each cycle) and carboplatin (area under the curve 3 on days 1 and 8 of each cycle) was administered every 21 days. Primary end point was objective response rate (ORR). RESULTS: Thirty patients were enrolled in the study, and the median follow-up duration was 19.8 months. Among 25 per-protocol patients, there were three responders (1 with complete response and 2 with partial response) and 17 stable disease patients (ORR, 12.0%). Among the per-protocol population, the median progression-free survival (PFS) was 4.3 months and the median overall survival (OS) was 9.6 months. Uveal melanoma patients (n=9) showed the best prognosis compared to other subtypes (median PFS, 7.6 months; OS, 9.9 months). The most common grade 3 or 4 adverse event was neutropenia (n=15, 50.0%). CONCLUSION: Docetaxel combined with carboplatin showed association with an acceptable safety profile and overall efficacy for patients with malignant melanoma who had progressed on chemotherapy containing dacarbazine.
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/141804
Files in This Item:
T201510010.pdf Download
DOI
10.4143/crt.2014.261
Appears in Collections:
1. Journal Papers (연구논문) > 1. College of Medicine (의과대학) > Dept. of Dermatology (피부과학교실)
Yonsei Authors
김혜련(Kim, Hye Ryun) ORCID logo https://orcid.org/0000-0002-1842-9070
김효송(Kim, Hyo Song)
노미령(Roh, Mi Ryung) ORCID logo https://orcid.org/0000-0002-6285-2490
라선영(Rha, Sun Young)
신상준(Shin, Sang Joon)
안중배(Ahn, Joong Bae)
이충근(Lee, Choong Kun)
정민규(Jung, Min Kyu) ORCID logo https://orcid.org/0000-0001-8281-3387
정현철(Chung, Hyun Cheol) ORCID logo https://orcid.org/0000-0002-0920-9471
최혜진(Choi, Hye Jin)
허수진(Heo, Su Jin)
Export
RIS (EndNote)
XLS (Excel)
XML
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse